Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort (“PEMBROREAL” Study)
Article in Cancers (May 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in Cancers (May 2024)
Article in Frontiers in Oncology (April 2024)
Article in Targeted Oncology (October 2023)